Dr. Tarek I. Hassanein, MD

Dr. Hassanein practices at Southern California Liver Centers Inc in Coronado, California.

Dr. Hassanein's NPI, 1801854450, was assigned on May 3, 2006. Dr. Hassanein holds California license A54452.

Dr. Hassanein's primary practice is Southern California Liver Centers Inc, at 131 Orange Ave, Coronado, CA 92118 in San Diego County. The practice phone is (619) 522-0399.

Dr. Hassanein's primary practice is Southern California Liver Centers Inc in Coronado, California. Dr. Hassanein is also affiliated with Sharp Coronado Hospital. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Hassanein to 4 more hospitals, 6 medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hassanein practices, 10 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Hassanein's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Hassanein is licensed in California.

CMS data shows 2,230 Medicare services from Dr. Hassanein across 13 procedure codes in 2024, for 837 Medicare patients. Medicare paid $202,163 for them.

CMS counts 837 Medicare patients who saw Dr. Hassanein in 2024. The largest group is 65 to 74, with 469 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 71% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hassanein's median patient age at 62, with 58% women.

In 2024, Dr. Hassanein wrote 3,321 Medicare Part D claims for 880 patients. 80% of them were for generic drugs. CMS names the drug for 3,004 of them, across 48 drugs with 11 or more claims each, at $2,483,254 in total drug cost. In 2023, CMS named 3,664 claims across 50 drugs.

Dr. Hassanein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hassanein as offering telehealth. CMS counts 133 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Hassanein, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 69 papers to Dr. Hassanein, published from 2010 to 2025. 2016 was the busiest year, with 8. The most frequent topics are Hepacivirus, Antiviral Agents and Hepatitis C, Chronic. Dr. Hassanein has published most often in Aliment Pharmacol Ther. Dr. Hassanein's most frequent co-authors are Parvez S. Mantry, MD, Kris V. Kowdley, MD and Nezam H. Afdhal, MD.

Dmand AI links Dr. Hassanein to 13 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Non-alcoholic Fatty Liver Disease, Fatty Liver and Liver Cirrhosis, Biliary. HepQuant, LLC sponsors the most, 3. Open Payments lists research payments to Dr. Hassanein that name 3 trials.

CMS Open Payments shows 622 general payments to Dr. Hassanein from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Abbvie Inc. paid the most, $204,196. It also lists 37 research payments totaling $143,437 from 2016 to 2021, naming 3 clinical trials.